Castenmiller, J., Hirsch‐Ernst, K., Kearney, J., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., . . . de Henauw, S. (2021). Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis. EFSA J.
Chicago-tyylinen lähdeviittausCastenmiller, Jacqueline, et al. "Efficacy of an Infant Formula Manufactured From a Specific Protein Hydrolysate Derived From Whey Protein Isolate and Concentrate Produced By Société Des Produits Nestlé S.A. in Reducing the Risk of Developing Atopic Dermatitis." EFSA J 2021.
MLA-viiteCastenmiller, Jacqueline, et al. "Efficacy of an Infant Formula Manufactured From a Specific Protein Hydrolysate Derived From Whey Protein Isolate and Concentrate Produced By Société Des Produits Nestlé S.A. in Reducing the Risk of Developing Atopic Dermatitis." EFSA J 2021.